Furthermore, co-expression of MDM2 and MDMX increased levels of co-transfected AR-GFP, a hybrid gene under the CMV promoter (Figure 5C), indicating that MDM2/MDMX co-expression increases the stability of AR in prostate cancer cells. The gene discussed is MDM2; the disease is prostate carcinoma.